找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Biopatent Law: Patent Strategies and Patent Management; Andreas Hübel,Thilo Schmelcher,Ulrich Storz Book 2012 Ulrich Storz 2012 Biopharmac

[复制链接]
查看: 32892|回复: 35
发表于 2025-3-21 17:32:28 | 显示全部楼层 |阅读模式
期刊全称Biopatent Law: Patent Strategies and Patent Management
影响因子2023Andreas Hübel,Thilo Schmelcher,Ulrich Storz
视频video
发行地址Improves the understanding of patent issues.Written by internationally active experts.Provides a clear overview of the basics of patent management and strategies.Includes supplementary material:
学科分类SpringerBriefs in Biotech Patents
图书封面Titlebook: Biopatent Law: Patent Strategies and Patent Management;  Andreas Hübel,Thilo Schmelcher,Ulrich Storz Book 2012 Ulrich Storz 2012 Biopharmac
影响因子.Patents protecting biotechnological invention are becoming ever more important. Because biotechnology has many differences with respect to other technologies, lessons learned in other fields of technology cannot simply be transferred to adopt a suitable strategy for dealing with biotechnology inventions. .In this volume, general aspects of biopatent law will be discussed. This involves questions of patentability, including ethical issues and issues of technicality, as well as questions of patent exhaustion in cases were reproducible subject matter, like cells or seeds, is protected. Moreover, active and passive patent strategies are addressed. Further, insight will be given into patent lifetime management and additional protective measures, like supplementary protection certificates and data exclusivity. Here, strategies are discussed how market exclusivity can be extended as long as possible, which is particularly important for biopharmaceutical drugs, which create high R&D costs..
Pindex Book 2012
The information of publication is updating

书目名称Biopatent Law: Patent Strategies and Patent Management影响因子(影响力)




书目名称Biopatent Law: Patent Strategies and Patent Management影响因子(影响力)学科排名




书目名称Biopatent Law: Patent Strategies and Patent Management网络公开度




书目名称Biopatent Law: Patent Strategies and Patent Management网络公开度学科排名




书目名称Biopatent Law: Patent Strategies and Patent Management被引频次




书目名称Biopatent Law: Patent Strategies and Patent Management被引频次学科排名




书目名称Biopatent Law: Patent Strategies and Patent Management年度引用




书目名称Biopatent Law: Patent Strategies and Patent Management年度引用学科排名




书目名称Biopatent Law: Patent Strategies and Patent Management读者反馈




书目名称Biopatent Law: Patent Strategies and Patent Management读者反馈学科排名




单选投票, 共有 0 人参与投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用户组没有投票权限
发表于 2025-3-21 22:33:30 | 显示全部楼层
发表于 2025-3-22 01:20:38 | 显示全部楼层
发表于 2025-3-22 04:37:02 | 显示全部楼层
Biopatent Law: Patent Strategies and Patent Management978-3-642-24846-7Series ISSN 2192-9904 Series E-ISSN 2192-9912
发表于 2025-3-22 11:34:56 | 显示全部楼层
发表于 2025-3-22 13:33:20 | 显示全部楼层
发表于 2025-3-22 18:57:33 | 显示全部楼层
https://doi.org/10.1007/978-3-642-24846-7Biopharmaceutics; Intellectual properties; Invention; Litigation strategies; Patent infringement
发表于 2025-3-23 00:53:08 | 显示全部楼层
https://doi.org/10.1007/978-3-662-46444-1ed requirements. However, unique requirements were established such that the peculiarities of biotechnological inventions can be considered. Nonetheless, it appears that certain specific regulations for obtaining patent protection for a biotechnological invention poses more burden to an applicant th
发表于 2025-3-23 02:33:39 | 显示全部楼层
https://doi.org/10.1007/978-3-662-43205-1ategies both from an active viewpoint as claimant and a passive viewpoint as a respondent. Active and passive will be interpreted with respect to an intellectual pro perty rights (IPR) portfolio and it will be interpreted in light of actions performed with respect to an IPR portfolio. Both views hav
发表于 2025-3-23 06:23:07 | 显示全部楼层
Laser Speckle and Related Phenomenad into research and development, their lifetime is restricted. However, due to lengthy authorisation processes for pharmaceutical products, biopharmaceutic innovators cannot exploit the full lifetime of their patents. In order to provide sufficient incentive to develop new drugs, all major countries
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-6-26 09:57
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表